
Four randomised controlled trials.
Zero doubt.
Bold is being the first company to conduct Level-1 comparative effectiveness trials directly comparing drug-eluting technologies. And we did it four times.
Eluvia DES Clinical Trials ›
Ranger DCB Clinical Trials ›
Drug-Eluting Technologies

Eluvia™ Drug-Eluting Vascular Stent System
Designed with sustained release to match the restenotic process of the SFA. Eluvia demonstrated superiority at 1-Year in two RCTS - bare metal stents in EMINENT2 and Zilver PTX in IMPERIAL3. No SFA stent has performed better at 2-Years. No matter the lesion complexity. No matter the patient.

Explore DE Resources
Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.

Stay Up to Date
Receive emails about the latest drug-eluting technology news, innovations and events in your area.
